Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Mirum Pharmaceuticals Ownership Summary


Mirum Pharmaceuticals is owned by 91.37% institutional investors, 2.78% insiders, and 5.85% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 13.84% of MIRM shares. Eventide Gilead N is the top mutual fund, with 2.92% of its assets in Mirum Pharmaceuticals shares.

MIRM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMirum Pharmaceuticals91.37%2.78%5.85%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management6.50M13.84%$222.08M
Janus henderson group4.58M9.59%$189.48M
Blackrock funding, inc. /de3.43M7.19%$142.02M
Blackrock3.24M6.90%$110.71M
Bvf inc/il2.80M5.85%$115.64M
Eventide asset management2.61M5.46%$107.80M
Vanguard group2.42M5.07%$100.26M
State street1.50M3.19%$51.16M
Novo1.50M3.14%$62.02M
Rock springs capital management lp1.47M3.08%$60.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Frazier life sciences management6.50M10.39%$222.08M
Boone capital management581.84K8.12%$24.06M
Nan fung group125.33K4.43%$5.18M
Bvf inc/il2.80M3.92%$115.64M
Novo1.50M3.76%$62.02M
First turn management506.91K3.75%$20.96M
Bioimpact capital589.58K3.46%$24.38M
Tang capital management1.24M3.38%$51.15M
Prosight management, lp314.80K3.22%$10.76M
Highlander partners122.98K2.89%$5.09M

Top Buyers

HolderShares% AssetsChange
Blackrock3.24M0.00%785.78K
Jpmorgan chase385.14K0.00%357.38K
Bnp paribas arbitrage, snc261.64K0.01%261.64K
Raymond james financial256.61K0.00%256.61K
Nuveen asset management722.15K0.01%229.75K

Top Sellers

HolderShares% AssetsChange
State street1.50M0.00%-1.33M
Eventide asset management2.61M1.96%-838.42K
William blair investment management---677.94K
Cadian capital management, lp---475.71K
Checkpoint capital---362.19K

New Positions

HolderShares% AssetsChangeValue
Bnp paribas arbitrage, snc261.64K0.01%261.64K$10.82M
Raymond james financial256.61K0.00%256.61K$10.61M
D. e. shaw157.35K0.00%157.35K$6.51M
Algert global68.29K0.07%68.29K$2.82M
Canada pension plan investment board41.80K0.00%41.80K$1.73M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Cibc private wealth group-10.00
Capital performance advisors llp-16.00
Bessemer group-30.00
Private wealth management group-35.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241945.43%43,660,980-17.71%910.74%109-3.54%5640.00%
Sep 30, 202418411.52%53,056,700-0.10%1110.87%11425.27%40-20.00%
Jun 30, 2024165-5.17%53,108,448-0.23%1130.88%91-3.19%50-3.85%
Mar 31, 2024174-8.42%53,228,8636.43%1130.99%94-18.97%521.96%
Dec 31, 202319019.50%50,012,6062.71%1070.76%11618.37%5159.38%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Gilead N1.43M2.92%-341.18K
Vanguard US Total Market Shares ETF1.41M2.87%1.77K
Vanguard Total Stock Mkt Idx Inv1.31M2.67%1.21K
Eventide Healthcare & Life Sciences I1.17M2.38%-498.97K
iShares Russell 2000 ETF1.04M2.13%-9.02K
Polar Capital Biotech S Inc1.00M2.04%-
US Small-Cap Growth II Equity Comp767.71K1.60%-660.00
Janus Henderson Global Life Sciences762.42K1.59%-63.30K
MEDICAL BioHealth EUR Acc756.50K1.59%-
T. Rowe Price New Horizons767.49K1.57%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 18, 2025Howe Jolanda SVP, GLOBAL CONTROLLERSell$107.34K
Mar 17, 2025Howe Jolanda SVP, GLOBAL CONTROLLERSell$80.11K
Mar 17, 2025Howe Jolanda SVP, GLOBAL CONTROLLERSell$2.22M
Mar 17, 2025Howe Jolanda SVP, GLOBAL CONTROLLERSell$124.80K
Mar 17, 2025Howe Jolanda SVP, GLOBAL CONTROLLERSell$128.22K

Insider Transactions Trends


DateBuySell
2025 Q11021
2024 Q4-1
2024 Q321
2024 Q2-2
2024 Q1211

MIRM Ownership FAQ


Who Owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals shareholders are primarily institutional investors at 91.37%, followed by 2.78% insiders and 5.85% retail investors. The average institutional ownership in Mirum Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Mirum Pharmaceuticals exceeds.

Who owns the most shares of Mirum Pharmaceuticals?

Mirum Pharmaceuticals’s largest shareholders are Frazier life sciences management (6.5M shares, 13.84%), Janus henderson group (4.58M shares, 9.59%), and Blackrock funding, inc. /de (3.43M shares, 7.19%). Together, they hold 30.62% of Mirum Pharmaceuticals’s total shares outstanding.

Does Blackrock own Mirum Pharmaceuticals?

Yes, BlackRock owns 6.90% of Mirum Pharmaceuticals, totaling 3.24M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 110.71M$. In the last quarter, BlackRock increased its holdings by 785.78K shares, a 32.04% change.

Who is Mirum Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Frazier life sciences management is Mirum Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.39% of its assets in 6.5M Mirum Pharmaceuticals shares, valued at 222.08M$.

Who is the top mutual fund holder of Mirum Pharmaceuticals shares?

Eventide Gilead N is the top mutual fund holder of Mirum Pharmaceuticals shares, with 2.92% of its total shares outstanding invested in 1.43M Mirum Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools